O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+2.22%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.05B
AUM Growth
+$5.05B
(-3.3%)
Cap. Flow
-$81.2M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
35.6%
Holding
132
New
17
Increased
26
Reduced
29
Closed
15
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
$173M |
| 2 |
Biogen
BIIB
|
$68.6M |
| 3 |
Eli Lilly
LLY
|
$63.9M |
| 4 |
Baxter International
BAX
|
$63.4M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$60M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$117M |
| 2 |
Pfizer
PFE
|
$71.4M |
| 3 |
Natera
NTRA
|
$54M |
| 4 |
UnitedHealth
UNH
|
$49.4M |
| 5 |
89bio
ETNB
|
$46.6M |
Sector Composition
| 1 | Healthcare | 97.56% |
| 2 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
51
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $32.1M | 0.63% |
5,143,629
+1,100,000
| +27% | +$6.88M |
|
52
AbCellera Biologics
ABCL
$1.19B
| $31.5M | 0.62% |
4,180,768
| – | – |
|
|
ALPN
53
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $31.5M | 0.62% |
4,081,592
| – | – |
|
54
PMV Pharmaceuticals
PMVP
$82.1M
| $31.3M | 0.61% |
6,563,077
| – | – |
|
55
Iovance Biotherapeutics
IOVA
$800M
| $28.8M | 0.56% |
4,707,458
+2,700,000
| +134% | +$16.5M |
|
56
Vaxcyte
PCVX
$4.17B
| $27.3M | 0.54% |
729,439
-553,687
| -43% | -$20.8M |
|
|
RCM
57
DELISTED
R1 RCM Inc. Common Stock
RCM
| $26.3M | 0.52% |
+1,750,000
| New | +$26.3M |
|
|
TSVT
58
DELISTED
2seventy bio
TSVT
| $24.4M | 0.48% |
2,391,628
+1,350,328
| +130% | +$13.8M |
|
59
Amylyx Pharmaceuticals
AMLX
$877M
| $23.9M | 0.47% |
+813,500
| New | +$23.9M |
|
|
THRD
60
DELISTED
Third Harmonic Bio
THRD
| $23.8M | 0.47% |
5,779,071
| – | – |
|
61
RAPT Therapeutics
RAPT
$187M
| $23M | 0.45% |
1,251,070
| – | – |
|
|
HZNP
62
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $21.8M | 0.43% |
200,000
+29,000
| +17% | +$3.17M |
|
63
Arcutis Biotherapeutics
ARQT
$1.91B
| $21.1M | 0.41% |
1,914,479
-545,629
| -22% | -$6M |
|
64
SPDR S&P Biotech ETF
XBI
$5.29B
| $20.9M | 0.41% |
274,000
+197,600
| +259% | +$15.1M |
|
65
RxSight
RXST
$364M
| $20.1M | 0.39% |
1,202,833
| – | – |
|
66
Regeneron Pharmaceuticals
REGN
$59.8B
| $19.7M | 0.39% |
+24,000
| New | +$19.7M |
|
67
Ventyx Biosciences
VTYX
$184M
| $19.6M | 0.38% |
585,000
-340,000
| -37% | -$11.4M |
|
68
Neuropace
NPCE
$310M
| $18.6M | 0.37% |
4,012,281
| – | – |
|
69
Amgen
AMGN
$153B
| $18.5M | 0.36% |
+76,700
| New | +$18.5M |
|
|
GRCL
70
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $17.7M | 0.35% |
9,497,774
+1,612,904
| +20% | +$3M |
|
71
Kezar Life Sciences
KZR
$28.5M
| $17.1M | 0.34% |
5,463,000
+878,678
| +19% | +$2.75M |
|
72
argenx
ARGX
$44.2B
| $16.6M | 0.33% |
44,500
+28,300
| +175% | +$10.5M |
|
73
Apollomics
APLM
$4.62M
| $16M | 0.31% |
+662,561
| New | +$16M |
|
|
JBIO
74
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $15.3M | 0.3% |
756,930
-2,610
| -0.3% | -$52.2K |
|
|
DBTX
75
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $14.9M | 0.29% |
4,945,192
| – | – |
|